Skip to main content
Understanding so you can act early

Pancreatic cancer

No organized cancer screening

15,991 new cases in France in 2023 1

What is it?

In more than 9 in 10 cases, this is an adenocarcinoma, arising from the cells lining the ducts of the pancreas, the gland that produces digestive juices 2.

How it develops

The cancer starts from precursor lesions: microscopic lesions in the small ducts (PanIN), invisible on imaging, or mucus-producing cysts (IPMN), visible on MRI. It may then reach the lymph nodes and later the liver 3.

How long does it take to develop?

According to a genetic study published in Nature, it may take at least 10 years from the first mutation to the development of cancer, then at least 5 more years before cells capable of forming metastases appear 4. This suggests a long detection window, although these figures come from a small number of patients.

Risk factors

  • Tobacco (risk multiplied by about 2,7)
  • Excess weight and obesity
  • Chronic pancreatitis and diabetes
  • Age
  • Family history and certain genes (BRCA2, PALB2, ATM, Lynch syndrome)

What helps protect you: Stopping smoking (after 20 years without smoking, the risk returns to that of a non-smoker), maintaining a healthy weight, limiting alcohol 5.

Signs that should prompt a visit to your doctor

  • Most often, no symptoms
  • They appear late
  • Loss of weight and appetite, fatigue
  • Digestive problems
  • New-onset diabetes
  • Jaundice: yellow skin and eyes, dark urine
  • Abdominal pain radiating to the back

These signs do not mean you have cancer: they may have other causes. Unsure? Talk to your doctor.

⁶

Often no symptoms at first. See a doctor for jaundice, dark urine, unexplained weight loss, abdominal or back pain, or recently developed diabetes. These signs most often have another cause 7.

Detected early or at a later stage

In the United States, only 15 % of pancreatic cancers are found at the localized stage, when surgery is often possible; 28 % at the regional stage, 51 % distant 8.

5-year survival by stage

FOUND AT A LATER STAGEFOUND EARLY
Localizedstages I–IIDistant : stade IV
3,4 %
43,6 %
Regionalstages II–III17,0 %

At the localized stage, survival is about 13 times higher than at the metastatic stage 8. In France, 5-year net survival: 11 % 9.

Approximate correspondence with the clinical classification (TNM/FIGO); this varies depending on the tumour's characteristics.

Screening in France

No. To date, no test has demonstrated a reduction in mortality in the general population 7.

Monitoring for people at risk

People at high familial or genetic risk may receive annual surveillance with endoscopic ultrasound and MRI at an expert center, starting at age 50 or 10 years before the age of the youngest affected relative 10.

A female doctor talking with a female patient in a bright consulting room
A concern or an unexplained symptom? Talk to your doctor.
Prevonco

Prevonco is currently available in France only.

An aid to the early detection of 16 cancers

No prescription needed, for people without symptoms. If you have an unexplained symptom, see your doctor first.

Pre-register for free →

Frequently asked questions

Do I need a prescription?

No. With Prevonco, you do not need a prescription: after ordering online, a unique code gives you access to the test at one of our partner laboratories. In France, some laboratory tests can be carried out at your request, without a prescription.

No prescription, but still a doctor: they remain central to the process. Your result is sent to the doctor you selected from our panel, who will explain it during a 30-minute video consultation, included whatever the result.

Are you receiving care for cancer? Speak directly to your oncologist: they can prescribe this test without going through Prevonco.

For any questions about your situation, or if you have symptoms, your doctor remains your first point of contact.

What if my level is high?

A high level tends to be a strong signal. It is not a conclusion: its cause needs to be investigated with a doctor.¹¹

Your result is sent to the doctor you selected from our panel. They will explain it during the 30-minute video consultation included in the price. Further investigations prescribed by a doctor can help identify the cause.¹¹

What if the level is intermediate? It may not be related to cancer (smoking, an inflammatory condition, etc.). Other blood tests may be suggested; if they are normal, a repeat check is planned at 12 months. You will never be left to face your result alone.¹¹

What if my level is low?

That is reassuring, but no test is perfect: a low level does not rule everything out.¹¹

If you have no symptoms, no specific follow-up is recommended after a low result. The risk of a false negative varies by cancer type.¹¹

Your doctor, who is trained in functional medicine and specialises in prevention, will help you explore any concerns or symptoms during the 30-minute video consultation.¹¹

Keep up with your usual screening: respond to invitations for organised screening programmes, and see your doctor if a symptom appears.¹¹

How long will it take to get my results?

The laboratory analysis takes 30 days. Your full results are presented by a doctor trained in functional medicine during a 30-minute consultation included in your package.

You choose the date and time slot that suit you for this appointment.

All frequently asked questions →
Prevonco

Prevonco is currently available in France only.

An aid to the early detection of 16 cancers

No prescription needed, for people without symptoms. If you have an unexplained symptom, see your doctor first.

Pre-register for free →